PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 120 filers reported holding PRINCIPIA BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $158,031,000 | +35.9% | 2,643,059 | +34.9% | 0.01% | 0.0% |
| Q1 2020 | $116,318,000 | +13.5% | 1,958,856 | +4.7% | 0.01% | +50.0% |
| Q4 2019 | $102,493,000 | +229.5% | 1,870,957 | +69.8% | 0.00% | +300.0% |
| Q3 2019 | $31,108,000 | -4.6% | 1,101,579 | +12.2% | 0.00% | 0.0% |
| Q2 2019 | $32,600,000 | +114.6% | 982,215 | +119.9% | 0.00% | 0.0% |
| Q1 2019 | $15,189,000 | +25.3% | 446,720 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $12,125,000 | +177.6% | 442,666 | +196.1% | 0.00% | – |
| Q3 2018 | $4,368,000 | – | 149,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |